Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christen Lykkegaard Andersen

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Ugeskrift for Laeger|January 29, 2010
[Discontinuation of antidepressant serotonergic antidepressant]Christen Lykkegaard Andersen, Poul Videbech
BMC Family Practice|May 16, 2019
Epstein-Barr virus and its association with disease - a review of relevance to general practiceAnders Fugl, Christen Lykkegaard Andersen
Leukemia Research|December 20, 2011
Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasmsChristen Lykkegaard Andersen, Hans Hasselbalch, Kirsten Grønbæk
Leukemia Research Reports|December 28, 2013
Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clonesChristen Lykkegaard Andersen, Fazila Asmar, Tobias Klausen, et al.
Clinical Epidemiology|March 6, 2024
The Copenhagen Primary Care Laboratory (CopLab) DatabaseMargit Kriegbaum, Bent Struer Lind, Mia Klinten Grand, et al.
European Journal of Haematology|February 11, 2018
Thromboembolism prophylaxis in patients with Philadelphia-negative myeloproliferative neoplasms-Clinical practice among Nordic specialistsOle Weis Bjerrum, Jan Samuelsson, Waleed Ghanima, et al.
European Journal of Haematology|March 22, 2017
A systematic review of health-related quality of life in longitudinal studies of myeloma patientsLene Kongsgaard Nielsen, Mary Jarden, Christen Lykkegaard Andersen, et al.
European Journal of Haematology|April 3, 2014
Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory stateMads Emil Bjørn, Christen Lykkegaard Andersen, Morten Krogh Jensen, et al.
Annals of Medicine and Surgery (2012)|July 31, 2019
Association of the blood eosinophil count with end-organ symptomsOle Weis Bjerrum, Volkert Siersma, Hans Carl Hasselbalch, et al.
European Journal of Haematology|August 1, 2025
Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in DenmarkKaroline Mathilde Lundgaard, Dustin Andersen Patel, Mette Brabrand, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Ugeskrift for Laeger|January 29, 2010
[Discontinuation of antidepressant serotonergic antidepressant]Christen Lykkegaard Andersen, Poul Videbech
BMC Family Practice|May 16, 2019
Epstein-Barr virus and its association with disease - a review of relevance to general practiceAnders Fugl, Christen Lykkegaard Andersen
Leukemia Research|December 20, 2011
Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasmsChristen Lykkegaard Andersen, Hans Hasselbalch, Kirsten Grønbæk
Leukemia Research Reports|December 28, 2013
Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clonesChristen Lykkegaard Andersen, Fazila Asmar, Tobias Klausen, et al.
Clinical Epidemiology|March 6, 2024
The Copenhagen Primary Care Laboratory (CopLab) DatabaseMargit Kriegbaum, Bent Struer Lind, Mia Klinten Grand, et al.
European Journal of Haematology|February 11, 2018
Thromboembolism prophylaxis in patients with Philadelphia-negative myeloproliferative neoplasms-Clinical practice among Nordic specialistsOle Weis Bjerrum, Jan Samuelsson, Waleed Ghanima, et al.
European Journal of Haematology|March 22, 2017
A systematic review of health-related quality of life in longitudinal studies of myeloma patientsLene Kongsgaard Nielsen, Mary Jarden, Christen Lykkegaard Andersen, et al.
European Journal of Haematology|April 3, 2014
Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory stateMads Emil Bjørn, Christen Lykkegaard Andersen, Morten Krogh Jensen, et al.
Annals of Medicine and Surgery (2012)|July 31, 2019
Association of the blood eosinophil count with end-organ symptomsOle Weis Bjerrum, Volkert Siersma, Hans Carl Hasselbalch, et al.
European Journal of Haematology|August 1, 2025
Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in DenmarkKaroline Mathilde Lundgaard, Dustin Andersen Patel, Mette Brabrand, et al.
Pageof 8